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Abstract 
Background: To evaluate the birth weight and post-natal non-coagulation problems of infants of mothers with 
coagulopathies versus normal mothers. Materials and Methods: In a retrospective cohort study, 100 women with 
coagulation problems attended the Iranian Haemophilia Comprehensive Care Center, and 200 normal women 
attending two health centers in Tehran and Karaj, with a history of at least one pregnancy were studied. A 
questionnaire about mothers’ and neonates’ condition was filled out by an interview, and the data were analyzed
using SPSS software, version 16. Results: Using linear regression, the maternal coagulation problem had a 
negative effect on birth weight (p<0.001, β= -0.31). The prevalence of early and prolonged jaundice in newborns 
of mothers with coagulopathy was higher than that in newborns of normal mothers (12% vs. 2%, and 7% vs. 3%, 
respectively), the difference between the two groups in terms of incidence of early jaundice was statistically 
significant (chi square-p<0.001). The frequency of using phototherapy and blood exchange for treating neonatal 
jaundice, in neonates of mothers with coagulopathy was higher than in neonates of normal mothers (31% vs. 21% 
and 8% vs. 21%, respectively) (p<0.001). Furthermore, the duration of hospitalization, hospitalization in NICU, 
and re-hospitalization during the first month of life in neonates of mothers with coagulation problems was higher 
than in neonates of normal mothers (p<0.001). Conclusion: Considering the high prevalence of neonatal problems 
in newborns of mothers with coagulation problems and their lower birth weight, further care measures should be 
provided for them. 
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Introduction 
Coagulopathies are a group of diseases in 
which the ability of the body in controlling blood 
coagulation is decreased or lost. Most coagulopathies 
are congenital, and if one of the parents is affected, 
the baby has a higher risk for the disorder. For 
instance, if the mother is affected by hemophilia A or 
B, all her sons will have the disease, and all her 
daughters will be carriers for the disease. If a mother is 
a carrier of the disease, half of her sons will inherit the 
disease, and half of her daughters will be carriers of 
the disease [1, 2]. Hemorrhage in infants with 
congenital coagulopathy disorders can be life-
threatening. Early diagnosis of the disorders in 
neonates and being sure of the appropriate treatment 
including the administration of coagulation factors and 
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early prophylaxis is very hard [3]. 
In a study on the relationship of pre- and post-
partum periods on the one hand and hemophilia A 
and B on the other hand, Arthur reported the 
prevalence of pre-term labor in mothers with 
coagulation disorders, was not significantly different 
from the rate in the general population. Moreover, 
the rate of blood exchange in their neonates was not 
higher than the general population [4]. 
In the evaluation of iron deficiency in women, 
Kulkarni et al. showed that bleeding disorders in 
women resulted in anemia, which in turn would 
cause pre-term labor and low birth weight in their 
babies [5].  
The study evaluated the effect of low birth 
weight on school performance and behavioral 
outcomes of elementary school children and 
demonstrated that the children with low birth weight 
had more problems in fulfillment of their school 
tasks and they have more health problems even until 
their adulthood [6]. 
In another study, Indredavik et al. studied the 
psychiatric symptoms and disorders in adolescents 
with low birth weight and concluded that 
adolescents, who were born with low and very low 
birth weights, will more frequently experience 
psychiatric disorders including anxiety in adulthood 
[7]. 
Furthermore, a study on the approaches in 
diagnosis and treatment of neonatal coagulopathies, 
stated that neonatal coagulation disorders will lead to 
different diseases including hepatic disorders, and the 
levels of hepatic enzymes would fluctuate [8]. 
Therefore, increased levels of bilirubin in newborns 
and coagulation disorders in their mothers may lead 
to jaundice in these neonates. The complications of 
jaundice are kernicterus, cerebral palsy, and auditory 
problems [9]. 
So, children born to mothers with 
coagulopathy may have bleeding complications as 
well as non-bleeding and many other problems at 
birth. In the current study, we have tried to identify 
these problems and their prevalence to help parents 
and physicians provide better care for these neonates. 
Methods 
This historical cohort study was carried out 
from July 2010 to June 2011 in the Iranian 
Haemophilia Comprehensive Care Center, two health 
centers in Tehran district 6, and Shahid Torkian health 
center in Karaj. The inclusion criteria were as follows: 
a history of at least one pregnancy and being in the age 
range of 20-45.  
The study population consisted of two groups: a 
coagulopathy group that consisted of 100 women with 
a coagulation disorder. Diagnosis of their disease was 
previously performed according to the results of 
laboratory tests, and they were registered in the Iranian 
Haemophilia Comprehensive Care Center. These 
women referred to the center from around the country 
to receive services. The normal group consisted of 200 
normal women who were referred to the above-
mentioned centers to receive services. 
Considering the very low prevalence rate of 
coagulation disorders in women, the sampling was 
carried out using an easy sampling method. To this 
end, until reaching the population size of the study, all 
women who referred to the centers and had the 
inclusion criteria were included in the study. For all 
participants, the data related to their last pregnancy 
and delivery was collected using a questionnaire. At 
the beginning of the study, using the viewpoints of 
obstetricians and internal medicine specialists, a 
questionnaire was prepared. It consisted of 80 items on 
demographic information, obstetric history, and 
delivery report, different aspects of delivery, neonates, 
post-partum complications, and neonate’s
hospitalization. For a pilot study, the questionnaire 
was handed out to 40 participants. The questionnaire 
pitfalls in data collection and interview were identified 
and modified (CVR= 0.73, CVI= 0.85, N= 10). 
The questionnaire contained items on 
characteristics of the baby and his/her problems at 
birth, which were asked from their mothers. The data 
was also obtained from the files and growth 
monitoring cards of the infants. 
Statistical analysis. The data were analyzed 
using SPSS software, version 15, with chi-square, and 
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logistic regression. Chi-square was used to compare 
the differences in bleeding complications in women 
with coagulation disorders and normal mothers. A 
logistic regression test was used to investigate the 
relationship between bleeding complications and 
coagulation disorders in women with coagulation 
disorders, along with the study of factors affecting 
bleeding complications. 
Results 
In the current study, 100 women with 
coagulation disorders and 200 normal women were 
evaluated. The anthropometric characteristics of 
participants including height and weight, last child’s
birth weight, and socioeconomic state Tables 1 and 2. 
The prevalence of neonates’ problems in different
groups is presented in Table 4.The frequency of the 
types of coagulopathy in the case group are as follow: 
Hemophilia (3%), hemophilia carrier (44%), von 
Willebrand (28%), factor VII deficiency (6%), factor 
X deficiency (3%), factor XI deficiency (2%), factor 
XII deficiency (2%), factor XIII deficiency 
(3%),hypofibrinogenemia(3%), Bernard-Soulier
syndrome(1%), Glanzmann’s syndrome(3%), factors
V and VIII deficiency(2%).   
Among the newborns of women studied, in the 
coagulopathy group, 56% of infants were male while 
the rate in normal women was 38%.
Table1. Physical and socioeconomic characteristics of women participated in the study (N= 300). 
Normal mothers; 
n (%) 
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Table2. Evaluation of physical characteristics of women participated in the study by T-test (N= 300). 
The mean birth weight of infants in 
coagulopathy and normal groups was 3018.2 ± 
546.95, and 3299.4 ± 456.89 gram, respectively. The 
difference in the birth weights of the two groups was 
not statistically significant. For more accurate 
comparison of the two groups, we used linear 
regression test and evaluated the effect of 
coagulopathy disorder of mothers and factors such as 
maternal age during pregnancy, occupation and 
education level, history of taking supplements, 
medications, and coagulation factors during 
pregnancy; hypertension, gestational diabetes, 
hyperemesis gravidarum, infection during pregnancy, 
multiple gestations, infants’ sex, infants’ coagulation
disorders, gestational age at the time of delivery on 
infant birth weight. According to the results obtained, 
maternal coagulopathy causes neonates’ low birth
weight (p<0.001, β= -0.17). Moreover, newborn sex 
had a significant effect on newborns’ birth weight
(Table 3). 
Table3. Factors effective on birth weight using linear regression analysis (N= 300).
Factors effective on birth weight Beta p-value 
Mother’s Coagulation Disorder -0.31 <0.001 
Mother’s Age During Pregnancy -0.10 0.08 
Mother’s Job -0.06 0.92 
Mother’s Education Level -0.02 0.63 
Drug Used During Pregnancy -0.08 0.15 
Administration Of Coagulation Factor During 
Pregnancy 
0.01 0.76 
Multiple Gestation -0.03 0.58 
Hyperemesis 0.000 0.86 
Infection During Pregnancy -0.05 0.31 
Gestational Diabetes -0.07 0.21 
Hypertension 0.07 0.19 
Neonate’s Sex -0.17 <0.001 
Gestational Age at Delivery -0.01 0.83 
Neonate’s Coagulation Disorder 0.06 0.28 
Normal mothers                                      
    
Mean                    Standard deviation                           
Mothers with coagulation disorders  
   Male              Standard deviation 
    p-value 
Mother’s age
(year) 
    32.42 7.31 32.61        7.07       0.74 
Mother’s weight
(kg) 
    61.61 9.14 64.06        10.61       0.54 
Mother’s height
(cm) 





    25.99 4.35 25.46       4.36                                0.67 
Neonate’s birth
weight (g) 
  3299.49 456.89 3018.26       546.95                                0.71 
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Duration of hospitalization 
One day after delivery 
One week after delivery 


















NCU hospitalization 5(2.5) 9(9) 14 0.013  
Re-hospitalization in the first 
month of life after the first 
hospital discharge 
1(0.5) 4(4) 5 0.041 
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In the comparison of babies born to the two 
groups of mothers, the following rate was obtained; 
the need for resuscitation (5% versus 3%), abnormal 
presentation of the fetus (3% versus 3.5%), abnormal 
respiration problems at birth (3% versus 2%), and 
congenital abnormalities (3% versus 2%) for 
coagulopathy and normal groups, respectively. 
Moreover, the rates of abnormal thyroid function test 
(1%) and abnormal auditory test (2%) were similar 
for both groups. The rates were not statistically 
significant using the chi-square test (Table 4). 
            Breastfeeding rate in the first 24 hours after 
birth was lower in newborns of the coagulopathy 
groups. However, exclusive breastfeeding was more 
frequent in the babies of the coagulopathy group, and 
the two groups were significantly different in this 
respect (p=0.03) (Table 4).  
In the coagulopathy and normal groups, the 
rates for early and prolonged jaundice were 12% 
versus 2%, and 7% versus 3%, respectively. The 
difference between the two groups in the prevalence 
of prolonged jaundice was statistically significant 
according to the results of the chi-square test 
(p<0.001). For jaundice treatment in the 
coagulopathy group, 31% and 8% of infants with 
jaundice received phototherapy and blood exchange, 
respectively (compared with 21% and 1.5% in the 
normal group) (p<0.001). According to the results of 
the logistic regression test, the effect of maternal 
coagulopathy disorder together with factors such as 
Rh, drugs, and administered coagulation factors 
during pregnancy, newborn’s birth weight and sex,
gestational age at the time of delivery, neonate’s
coagulation disorder, neonate’s feeding in the first 24
hours after delivery on the incidence of neonatal 
jaundice were evaluated. According to the results, 
maternal coagulation disorder led to a two-fold 
increase in the risk of neonatal jaundice (p= 0.01, 
odds ratio= 2.10, 9.3 < CI < 11) (Table 5). 
           The duration of the neonate’s hospital stay in
the coagulopathy group was higher than that in the 
normal group (p<0.001). Furthermore, the rate of 
hospitalization in NICU and re-hospitalization after 
the first hospital discharge in the first month of life 
was higher in neonates of the coagulopathy group 
(p<0.001). 
Table5. Factors effective on neonatal jaundice (logistic 
regression test, N= 300). 




Mother’s Rh 0.5 0.18 
Administration of 
coagulation factors during 
pregnancy 
1.13 0.86 
Use of drugs during 
pregnancy 
0.31 0.06 
Neonate’s sex 1.08 0.74 
Gestational age at the time of 
delivery 
0.78 0.42 
Baby feeding in the first 24 






           Coagulation disorders are classified as 
bleeding disorders, which are mostly congenital and 
the infected should deal with the disease during all 
his life. Pregnant women with coagulation disorders 
encounter two challenges; bleeding complications 
and the occurrence of the disorder in their baby [4]. 
As it was observed in the current study, many babies 
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born to these mothers were affected by coagulation 
disorders. 
It was observed that the coagulation disorder 
of the mother negatively affects the birth weight. In 
general, the problem can be the result of taking some 
drugs or administration of coagulation factors during 
pregnancy. In different studies, it was demonstrated 
that using desmopressin increases the risk of pre-
term labor [10]. In a study on neonatal coagulation 
defects, Turner stated that most neonates with severe 
coagulation disorders were pre-term and had birth 
weight under 2000 g. [11]. In the current study, it 
was observed that neonate’s coagulation disorder did
not affect birth weight. If the current study was 
performed on a larger sample size, such a 
relationship could probably be found. However, in 
the study by Turner, the role of maternal coagulation 
disorder was not considered. Coagulation disorders 
are mostly congenital and newborns with such 
disorders and low birth weight are probably born to 
mothers who have coagulation disorders or at least 
they are carriers of the disease, and such conditions 
may affect neonate’s birth weight. In a study on
pregnancy and rare bleeding disorders, Kadir et al. 
reported cases of pre-term labor and very low birth 
weight in neonates born to mothers with coagulation 
disorders [12]. Nevertheless, in the current study, we 
did not observe cases of low birth weight (LBW) or 
very low birth weight (VLBW). If the study was 
carried out on a larger population size, the effect of 
maternal coagulation disorders on birth weight or 
LBW and VLBT could be evaluated with higher 
confidence. 
Physiological jaundice begins at the second 
and third days of life, usually peaks at days third to 
fifth and sometimes seventh, and then within two to 
three days, the bilirubin level declines to normal. The 
phenomenon is considered to be pathological if the 
time of occurrence, duration, or serum bilirubin 
levels in serial measurements are significantly 
different from those of physiological jaundice. The 
pathological jaundice is associated with maternal or 
neonatal factors (perinatal problems; or underlying 
genetic, hematologic, or metabolic diseases) [13]. 
In the current study, it was demonstrated that 
maternal coagulation disorder increases the risk of 
pathologic jaundice occurrence (early and prolonged 
jaundice) and the need for its treatment 
(phototherapy and blood exchange). The risk of 
occurrence of jaundice in babies born to mothers 
with coagulation disorders is almost two times of 
babies having normal mothers. Jaundice can be 
caused by hepatic failure associated with hemostatic 
abnormalities. 
The underlying mechanisms of hepatic failure 
associated with hemostatic disorders are decreased 
synthesis of coagulation factors, decreased activity of 
coagulation and fibrinolytic systems, ineffective 
clearance of active hemostatic complexes, 
coagulation protein deficiency, thrombocytopenia, 
platelet dysfunction, and abnormal vitamin K intake 
[14]. Hyperbilirubinemia occurs in pre-term 
neonates, or neonates with neonatal intraventricular 
hemorrhages, concealed hemorrhages, and hemolysis 
[11]. Furthermore, in babies born to mothers with 
coagulation disorders, the level of coagulation factor 
is decreased and the risk of neonatal hemorrhages 
including cephalhematoma, intraventricular 
hemorrhages, and concealed hemorrhages is higher. 
This can be a predisposing factor for the occurrence 
of hyperbilirubinemia and jaundice in these 
newborns [15]. 
A higher rate of blood exchange in the 
treatment of neonatal jaundice for babies of mothers 
with coagulation disorders can be the result higher 
prevalence of bleeding disorders and hemorrhage and 
thus a higher prevalence of hyperbilirubinemia in 
these newborns. This would convince the physicians 
to employ blood exchange for the treatment of 
hyperbilirubinemia. Furthermore, since the data of 
the current study were collected using interviews 
with mothers, mothers may mistake blood exchange 
with any cause for blood exchange as a treatment of 
jaundice [13]. 
The values obtained for the duration of 
hospitalization, hospitalization in NICU, and re-
hospitalization after the first hospital discharge in the 
first month of life were higher for babies of mothers 
with coagulation problems [16]. In the current study, 
the neonates were evaluated for coagulation 
disorders. Moreover, babies of mothers who were 
aware of their disease were observed, and re-
hospitalization because of circumcision or other 
neonatal hemorrhages were recorded. A major cause 
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of re-admission in neonates of mothers with 
coagulation problems was the occurrence of 
jaundice. 
We have classified the mothers’ coagulation
disorders according to the disorder type. However, 
since the number of cases for each disease was low, 
the effect of each disease on other factors was not 
evaluated. Thus, the classification of disorders was 
used only for the description of mothers’ condition,
and regardless of the disease type, coagulation 
disorders, in general, were considered in the study. 
The neonates’ sex in the two groups was
expected to be similar or because of the higher rate 
of abortion of affected male fetuses, the number of 
the female newborns in mothers with coagulation 
disorders be higher. Nevertheless, the number of 
male newborns in the coagulopathy group was 
higher, and the difference between the two groups in 
this respect was statistically significant. In some 
cases, sampling in the group of mothers with 
coagulation disorders performed by identification of 
boys with hemophilia, and as their mothers were 
carriers for hemophilia, they were included in the 
study. This can explain the sex difference observed 
between the babies of the two groups. Thus, the 
difference originates from the sampling method. 
The prevalence of coagulation disorders 
among babies of mothers with coagulation disorder 
was determined to be 97%. The rate was higher than 
that reported by others [17-19]. This is also the result 
of the sampling method, as in some cases after 
identification of the affected child; his mother was 
included in the study. Considering the results of 
previous studies, it was expected that mothers who 
feed their babies with their milk in the first 24 hours 
of life would follow exclusive breastfeeding more 
frequently. However, it was observed that the rate of 
breastfeeding in the first 24 hours was lower in the 
coagulopathy group, while the rate of exclusive 
breastfeeding was higher in this group. Many 
mothers with coagulation disorders lived in towns 
other than Tehran, and many have experienced 
delivery in hospitals, which were not mother-
friendly, and did not insist on early breastfeeding. 
This can explain the observation of the study. 
Moreover, considering the lifestyle in Iranian towns 
and not prescribing a formula for pre-term neonates 
by midwives and physicians, such difference is 
expected. For instance, none of the mothers with 
coagulation disorders used formula for their pre-term 
babies. 
As maternal coagulation disorder leads to 
some problems for neonates, these women should be 
prepared for dealing with the problems. For instance, 
during pregnancy, they should receive consultation 
from obstetricians and pediatricians. Besides, by 
receiving complete pregnancy care, preterm labor 
and LBW should be prevented; the delivery should 
be performed in centers with units such as NICU that 
is required for providing care and treatment to these 
newborns. The neonates should also be examined for 
coagulation diseases at birth to prevent the 
occurrence of future problems. If jaundice occurred, 
the pediatrician should be aware of the mothers’
history of the disease, and the treatment with 
minimal harm to the child be provided. Considering 
the problems that occurred for the newborn and their 
longer hospitalization, health care providers should 
concern the risk of nosocomial infections. 
Conclusion 
           In general, concerning the lower birth weight 
and higher prevalence of jaundice in neonates of 
mothers with coagulation disorders as well as the 
longer duration and higher frequency of their 
hospitalization, they should be treated more carefully 
and the neonatologist should be aware of mothers’
disease history. 
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